Manganese exposure induces microglia activation and dystrophy in the substantia nigra of non-human primates

NeuroToxicology

Volumn 32, Issue 2, 2011, Pages 215-226

  Verina, Tatyana ^a   Kiihl, Samara F ^a   Schneider, Jay S ^b   Guilarte, Tomás R ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Activation; Dystrophy; Ferric iron; Ferritin; INOS; Manganese; Microglia; Neurotoxicity; Substantia nigra

Indexed keywords

FERRIC ION; FERRITIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CELL COUNT; CELL FUNCTION; CELL LABELING; CELL STRUCTURE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; IMMUNOHISTOCHEMISTRY; LONG TERM EXPOSURE; MACACA; MALE; MICROGLIA; NERVE CELL DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PARKINSONISM; PHENOTYPE; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS COMPACTA; SUBSTANTIA NIGRA PARS RETICULATA;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MACACA; MACACA FASCICULARIS; MALE; MANGANESE; MICROGLIA; MUSCULAR DYSTROPHIES; NERVE DEGENERATION; SUBSTANTIA NIGRA;

ANIMALIA; MACACA; PRIMATES;

EID: 79952107427     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2010.11.003     Document Type: Article

References (84)

1. Agrawal R., Sharma P.K., Rao G.S. Release of iron from ferritin by metabolites of benzene and superoxide radical generating agents. Toxicology 2001, 168:223-230.
2. Agresti A. Categorical Data Analysis 2002, John Wiley and sons Inc, Hoboken, NJ. 2nd edition.
3. Aschner M., Erikson K.M., Dorman D.C. Manganese dosimetry: species differences and implications for neurotoxicity. Crit Rev Toxicol 2005, 35:1-32.
4. Banta R.G., Markesbery W.R. Elevated manganese levels associated with dementia and extrapyramidal signs. Neurology 1977, 27:213-216.
5. Barbeau A. Manganese and extrapyramidal disorders (a critical review and tribute to Dr George C Cotzias). Neurotoxicology 1984, 5:13-35.
6. Bartzokis G., Cummings J.L., Markham C.H., Marmarelis P.Z., Treciokas L.J., Tishler T.A., Marder S.R., Mintz J. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999, 17:213-222.
7. Beard J.L., Connor J.D., Jones B.C. Brain iron: location and function. Prog Food Nutr Sci 1993, 17:183-221.
8. Benarroch E.E. Brain iron homeostasis and neurodegenerative disease. Neurology 2009, 72:1436-1440.
9. Biemond P., Van Eijk H.G., Swaak A.J.G., Koster J.F. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: possible mechanism in inflammation diseases. J Clin Invest 1984, 73:1576-1579.
10. Braak H., Del Tredici K., Rub U., de Vos R.A.I., Jansen Steur E.N.H., Braak E. Stanging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003, 24:197-211.
11. Brooks D.J., Frey K.A., Marek K.L., Oakes D., Paty D., Prentice R., Shults C.W., Stoessl A.J. Imaging end points for monitoring neuroprotection in Parkinson's disease. Ann Neurol 2003, 53(Suppl. 3):S110-S118. discussion S118-9.
12. Burton N.C., Guilarte T.R. Manganese neurotoxicity: lessons learned from longitudinal studies in nonhuman primates. Environ Health Perspect 2009, 117:325-332.
13. Campbell A., Becaria A., Lahiri D.K., Sharman K., Bondy S.C. Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain. J Neurosci Res 2004, 75:565-572.
14. Cheepsunthorn P., Palmer C., Connor J.R. Cellular distribution of ferritin subunits in postnatal rat brain. J Comp Neurol 1998, 400:73-86.
15. Colton C.A., Gilbert D.L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987, 223:284-288.
16. Conde J.R., Streit W.J. Microglia in the aging brain. Neuropathol Exp Neurol 2006, 65:199-203.
17. Connor J.R., Menzies S.L., St Martin S.M., Mufson E.J. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J Neurosci Res 1992, 31:75-83.
18. Connor J.R., Boeshore K.L., Benkovic S.A., Menzies S.L. Isoforms of ferritin have a specific cellular distribution in the brain. J Neurosci Res 1994, 37:461-465.
19. Connor J.R., Menzies S.L. Cellular management of iron in the brain. J Neurol Sci 1995, 134(Suppl.):33-44.
20. Connor J.R., Snyder B.S., Arosio P., Loeffler D.A., LeWitt P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's disease brains. J Neurochem 1995, 65:717-724.
21. Connor J.R., Menzies S.L. Relationship of iron to oligodendrocytes and myelination. Glia 1996, 2:83-93.
22. Corradin S.B., Mauel J., Donini S.D., Quattrocchi E., Ricciardi-Castagnoli P. Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 1993, 7:255-262.
23. Desole M.S., Miele M., Esposito G., Migheli R., Fresu L., De Natale G., Miele E. Dopaminergic system activity and cellular defense mechanisms in the striatum and striatal synaptosomes of the rat subchronically exposed to manganese. Arch Toxicol 1994, 68:566-570.
24. Dexter D.T., Carayon A., Javoy-Agid F., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114:1953-1975.
25. Dobson A.W, Weber S., Dorman D.C., Lash L.K., Erikson K.M., Aschner M. Oxidative stress is induced in the rat brain following repeated inhalation exposure to manganese sulfate. Biol Trace Elem Res 2003, 93:113-126.
26. Dorman D.C., Struve M.F., Wong B.A., Dye J.A., Robertson I.D. Correlation of brain magnetic resonance imaging changes with pallidal manganese concentrations in rhesus monkeys following subchronic manganese inhalation. Toxicol Sci 2006, 92:219-227.
27. Erikson K.M., Dorman D.C., Lash L.H., Aschner M. Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol Sci 2007, 97:459-466.
28. Flanary B.E., Sammons N.W., Nguyen C., Walker D., Streit W.J. Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res 2007, 10:61-74.
29. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B. Altered brain metabolism of iron as a cause of neurodegenerative diseases?. J Neurochem 1994, 63:79L 807.
30. Griffiths P.D., Crossman A.R. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 1993, 4:61-65.
31. Griffiths P.D., Dobson B.R., Jones G.R., Clarke D.T. Iron in the basal ganglia in Parkinson's disease An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 1999, 122:667-673.
32. Guilarte T.R. Manganese and Parkinson's disease: a critical review and new findings. Environ Health Perspect 2010, 118:1071-1080.
33. Guilarte T.R., Chen M.K., McGlothan J.L., Verina T., Wong D.F., Zhou Y., Alexander M., Rohde C.A., Syversen T., Decamp E., Koser A.J., Fritz S., Gonczi H., Anderson D.W., Schneider J.S. Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates. Exp Neurol 2006, 202:381-390.
34. Guilarte T.R., McGlothan J.L., Degaonkar M., Chen M.K., Barker P.B., Syversen T., Schneider J.S. Evidence for cortical dysfunction and widespread manganese accumulation in the nonhuman primate brain following chronic manganese exposure: a 1H-MRS and MRI study. Toxicol Sci 2006, 4:351-358.
35. Guilarte T.R., Burton N.C., McGlothan J.L., Verina T., Zhou Y., Alexander M., Pham L., Griswold M., Wong D.F., Syversen T., Schneider J.S. Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism. J Neurochem 2008, 107:1236-1247.
36. Guilarte T.R., Burton N.C., Verina T., Prabhu V.V., Becker K.G., Syversen T., Schneider J.S. Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates. J Neurochem 2008, 105:1948-1959.
37. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482-488.
38. Han J., Day J.R., Connor J.R., Beard J.L. H- and L-ferritin subunit mRNA expression differs in brains of control and iron-deficient rats. J Nutr 2002, 132:2769-2774.
39. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387-1394.
40. Hill J., Switzer R. The regional distribution and cellular localization of iron in the rat brain. Neuroscience 1984, 11:595-603.
41. Huang C.C., Weng Y.H., Lu C.S., Chu N.S., Yen T.C. Dopamine transporter binding in chronic manganese intoxication. J Neurol 2003, 250:1335-1339.
42. Huang E., Ong W.Y., Connor J.R. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neurosci 2004, 128:487-496.
43. Jellinger K., Paulus W., Grundke-Iqbal I., Riederer P., Youdim M.B. Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm Park Dis Dement Sect 1990, 2:327-340.
44. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 2000, 20:6309-6316.
45. Kim Y., Kim J.M., Kim J.W., Yoo C.I., Lee C.R., Lee J.H., Kim H.K., Yang S.O., Chung H.K., Lee D.S., Jeon B. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?. Mov Disord 2002, 17:568-575.
46. Koller W.C., Lyons K.E., Truly W. Effect of levodopa treatment for parkinsonism in welders: a double-blind study. Neurology 2004, 62:730-733.
47. Kyrkanides S., O'Banion M.K., Whiteley P.E., Daeschner J.C., Olschowka J.A. Enhanced glial activation and expression of specific CNS inflammation-related molecules in aged versus young rats following cortical stab injury. J Neuroimmunol 2001, 9:269-277.
48. Lawson L.J., Perry V.H., Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39:151-170.
49. Lees A.J. l-Dopa treatment and Parkinson's disease. Q J Med 1986, 59:535-547.
50. Levi S., Yewdall S.J., Harrison P.M., Santambrogio P., Cozzi A., Rovida E., Albertini A., Arosio P. Evidence of H- and L-chains have co-operative roles in the iron-uptake mechanism of human ferritin. Biochem J 1992, 288:591-596.
51. Lopes K.O., Sparks D.L., Streit W.J. Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia 2008, 56:1048-1060.
52. Mann V.M., Cooper J.M., Daniel S.E., Srai K., Jenner P., Marsden C.D., Schapira A.H. Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann Neurol 1994, 36:876-881.
53. Martin C.J. Manganese neurotoxicity: connecting the dots along the continuum of dysfunction. Neurotoxicology 2006, 27:347-349.
54. Melega W.P., Lacan G., Harvey D.C., Way B.M. Methamphetamine increases basal ganglia iron to levels observed in aging. Neuroreport 2007, 18:1741-1745.
55. Mehlhase J., Sandig G., Pantopoulos K., Grune T. Oxidation-induced ferritin turnover in microglial cells: role of proteasome. Free Radic Biol Med 2005, 38:276-285.
56. Mehlhase J., Gieche J., Widmer R., Grune T. Ferritin levels in microglia depend upon activation: Modulation by reactive oxygen species. Biochim Biophys Acta-Mol Cell Res 2006, 1763:854-859.
57. Miles J.M., Chou S.M. A new immunoperoxidase marker for microglia in paraffin section. J Neuropathol Exp Neurol 1988, 47:579-587.
58. Parmley R.T., Spicer S.S., Alvarez C.J. Ultrastructural localization of nonheme cellular iron with ferrocyanide. J Histochem Cytochem 1978, 26:729-741.
59. Perl D.P., Olanow C.W. The neuropathology of manganese-induced Parkinsonism. J Neuropathol Exp Neurol 2007, 66:675-682.
60. R Development Core Team R: A Language and Environment for Statistical Computing 2009, R Foundation for Statistical Computing, Vienna, Austria.
61. Ren M.Q., Ong W.Y., Wang X.S., Watt F. A nuclear microscopic and histochemical study of iron concentrations and distribution in the midbrain of two age groups of monkeys unilaterally injected with MPTP. Exp Neurol 2003, 184:947-954.
62. Riederer P., Sofic E., Rausch W.D., Schmidt B., Reynold G.P., Jellinger K., Youdim M.B.H. Transition metals, ferritin, glutathion, and ascorbic acid in parkinsonian brains. J Neurochem 1989, 52:515-520.
63. Riederer P., Dirr A., Goetz M., Sofic E., Jellinger K., Youdim M.B. Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease. Ann Neurol 1992, 32(Suppl.):S101-S104.
64. Schneider J.S., Decamp E., Koser A.J., Fritz S., Gonczi H., Syversen T., Guilarte T.R. Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates. Brain Res 2006, 1118:222-231.
65. Schneider J.S., Decamp E., Clark K., Bouquio C., Syversen T., Guilarte T.R. Effects of chronic manganese exposure on working memory in non-human primates. Brain Res 2009, 1258:86-95.
66. Selikhova M., Fedoryshyn L., Matviyenko Y., Komnatska I., Kyrylchuk M., Krolicki L., Friedman A., Taylor A., Jäger H.R., Lees A., Sanotsky Y. Parkinsonism and dystonia caused by the illicit use of ephedrone-a longitudinal study. Mov Disord 2008, 23:2224-2231.
67. Sierra A., Gottfried-Blackmore A.C., McEwen B.S., Bulloch K. Microglia derived from aging mice exhibit an altered inflammatory profile. Gila 2007, 55:412-424.
68. Sikk K., Taba P., Haldre S., Bergquist J., Nyholm D., Askmark H., Danfors T., Sörensen J., Thurfjell L., Raininko R., Eriksson R., Flink R., Färnstrand C., Aquilonius S.M. Clinical, neuroimaging and neurophysiological features in addicts with manganese-ephedrone exposure. Acta Neurol Scand 2010, 121:237-243.
69. Sipe J.C., Lee P., Beutler E. Brain iron metabolism and neurodegenerative disorders. Dev Neurosci 2002, 24:188-196.
70. Sofic E., Riederer P., Heinsen H., Beckmann H., Reynolds G.P., Hebenstreit G., Youdim M.B. Increased iron (III) and total iron content in postmortem substantia nigra of parkinsonian brain. J Neural Transm 1988, 74:199-205.
71. Sofic E., Paulus W., Jellinger K., Riederer P., Youdim M.B. Selective increase of iron in the substantia nigra zona compacta of parkinsonian brains. J Neurochem 1991, 56:978-982.
72. Streit W.J., Sparks D.L. Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits. J Mol Med 1997, 75:130-138.
73. Streit W.J. Role of macrophages and microglia in the injured CNS. CNS Injures: Cellular Responses and Pharmacological Strategies 1999, CRS Press, Boca raton, p. 81-9.
74. Streit W.J., Sammons N.W., Kuhns A.J., Sparks D.L. Dystrophic microglia in the aging human brain. Glia 2004, 45:208-212.
75. Streit W.J. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci 2006, 29:506-551.
76. Streit W.J., Miller K.R., Lopes K.O., Njie E. Microglial degeneration in the aging brain-bad news for neurons?. Front Biosci 2008, 13:3423-3438.
77. Thomson A.M., Rogers J.T., Leedman P.J. Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int J Biochem Cell Biol 1999, 31:1139-1152.
78. Verity M.A. Manganese neurotoxicity: a mechanistic hypothesis. NeuroToxicology 1999, 20:489-497.
79. Youdim M.B., Grunblatt E., Mandel S. The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration: prospects for neuroprotection in Parkinson's disease with iron chelators. Ann N Y Acad Sci 1999, 890:7-25.
80. Zecca L., Youdim M.B., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004, 5:863-873.
81. Zhang X., Surguladze N., Slagle-Webb B., Cozzi A., Connor J.R. Cellular iron status influences the functional relationship between microglia and oligodendrocytes. Glia 2006, 54:795-804.
82. Zheng W., Ren S., Graziano J.H. Manganese inhibits mitochondrial aconitase: a mechanism of manganese neurotoxicity. Brain Res 1998, 799(July (2)):334-342.
83. Zheng W., Zhao Q. Iron overload following manganese exposure in cultured neuronal, but not neuroglial cells. Brain Res 2001, 897:175-179.
84. Zheng W., Zhao Q., Slavkovich V., Aschner M., Graziano J.H. Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res 1999, 833:125-132.